The Osteoblast-Adhesive Peptide, commonly referred to by its sequence KRSR (Lys-Arg-Ser-Arg), is a specialized peptide that plays a crucial role in bone tissue engineering and the development of advanced biomaterials for dental and orthopedic applications. Its unique ability to selectively enhance heparan sulfate-mediated osteoblast adhesion makes it an invaluable tool in both research and clinical settings.
Applications in Biological Research and Drug Development
KRSR is particularly significant in the field of bone-cell/tissue engineering. By promoting the adhesion of osteoblasts—the cells responsible for bone formation-this peptide facilitates the integration and stabilization of biomaterials in bone tissues. This characteristic is essential when designing dental implants or orthopedic devices that need to bond effectively with existing bone structures.
Additionally, the KRSR peptide is of interest in the design of next-generation biomaterials aimed at improving patient outcomes in bone repair and regeneration. Its role in enhancing cell adhesion suggests potential applications in drug delivery systems where targeting bone tissues is required.
This peptide is stored and handled under specific conditions to maintain its stability, typically at temperatures below -15°C, and it is soluble in DMSO, making it versatile for various experimental setups.
For researchers and developers working in the areas of tissue engineering, regenerative medicine, or biomaterial design, KRSR presents a powerful tool that can enhance the effectiveness of their applications | 